Financials
- Market Capitalization 539.02 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.25
ratio cours/chiffre d'affaires
1.9
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2423 | CSTL Castle Biosciences, Inc. - Common stock | 33.44 USD | +1.24% | -1.39% | +20.16% | +35.85% | 1.02 B USD | ||
| 2509 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.02 USD | -0.50% | -7.81% | +15.99% | +201.00% | 886.14 M USD | ||
| 3000 | PRE Prenetics Global Limited - Class A Ordinary Share | 25.81 USD | -1.68% | +7.77% | +32.70% | +226.71% | 435.52 M USD | ||
| 3290 | MYGN Myriad Genetics, Inc. - Common Stock | 3.18 USD | -1.24% | 0.00% | +11.19% | -61.55% | 304.17 M USD |